In this interview with Amy Siegel, we learn about 4 trends that medtech start-ups should be considering when trying to raise venture capital.
You May Like These Articles
Why Your Medical Device Company Needs Different Value Props For Different Stakeholders: Interview With Steve Anderson, Co-Founder and CEO of Preceptis Medical
Preceptis Medical CEO Steve Anderson explains how to keep all of your stakeholders in mind from the start, why having a voice of experience can help you navigate the process of getting to market, and why you should check and recheck your study protocols.
Why You Can’t Build a Medtech Start-Up Without Publicity: Interview with Peter Vranes, CEO of Nutromics
Peter Vranes, the co-CEO of wearable molecule-tracking patch Nutromics, explains how he learned to embrace publicity as a necessary part of doing business, why getting your device approved goes beyond government regulatory bodies, and the reasons he never stops raising money.
Doubling Down on Your Mission by Diversifying Your Medtech Portfolio: Interview With ReShape Lifesciences CEO Bart Bandy
ReShape Lifesciences CEO Bart Bandy explains how to put together a presentation that will land with every audience and how he approached moving manufacturing from Costa Rica to the U.S.
When You Should Give a Struggling Medtech Company a Second Chance: Interview With IONIQ CEO Jared Bauer
IONIQ Sciences CEO Jared Bauer explains why finding investors who care personally about your mission is a strategic benefit, and why he hopes that IONIQ’s devices will one day have a place in your medicine cabinet.
Conquering the Coverage and Reimbursement Landscape: Interview with Bruce Shook, President of Intact Vascular
In this interview, Bruce Shook discusses medical device insurance coverage and reimbursement, as well as advice for other healthcare entrepreneurs that need to raise money.
Why Curiosity and Persistence are Crucial Characteristics for Medtech Entrepreneurs: Interview with the Legendary Dr. John Simpson, Executive Chairman of Avinger
In this interview, the legendary Dr. John Simpson shares what drew him to the field of cardiology, his approach to building a medtech team, and why knowing your strengths and limitations is key to making a difference in the lives of others.
After Selling 2 Cardiovascular Companies for Over $1 Billion, Duke Rohlen is Now Hoping to do the Same with Spirox and Advanced Cardiac Therapeutics
In this interview with Duke Rohen, he discusses how he successfully led two early-stage medtech companies at the same time and the major lessons he learned raising money for 4 different medical device companies.
Having a Heart Attack? There’s an App for That! The Incredible Story of How Dr. David Albert Brought the ECG iPhone App to Market
In this interview with Dr. David Albert, we learn about his incredible journey in bringing the first iPhone ECG app to market with AliveCor.
Why Early Stage Medical Device Deals Aren’t as Bad as You May Think: Interview with Mike Carusi, General Partner at Lightstone Ventures
In this interview with medtech venture capitalist, Mike Carusi, he explains why early-stage medical device companies should look at biotech and pharma for creative ways to fund their companies.
Is Medtech Venture Capital Dead in the Water? Interview with Kevin Bitterman, Principal at Polaris Venture Partners
In this interview with Kevin Bitterman, we learn what medtech venture capitalists like to see in a startup and how these early-stage medical device companies can best position themselves for success.
How to Fund Medtech Startups in a Capital-Efficient Manner: Interview with Rich Ferrari, Managing Director of De Novo Ventures
In this interview with Rich Ferrari of De Novo Ventures, we learn more about the current state of medtech venture capital and the impact on medical device startups.
In this interview with Lisa Suennen, we learn why medical device companies will need to adjust their business models to succeed in today's healthcare environment.